AZN
ASTRAZENECA PLCThis quarter's activity
New positions opened
Positions exited
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026(8Q snapshot) | 1Q | $0.00 | — | — |
| Two Sigma Investments | Q2 2026(8Q snapshot) | 1Q | $0.00 | — | — |
| D.E. Shaw | Q2 2026(8Q snapshot) | 1Q | $0.00 | — | — |
| AQR Capital Management | Q2 2026(8Q snapshot) | 1Q | $0.00 | — | — |
| Millennium Management | Q2 2026(8Q snapshot) | 1Q | $0.00 | — | — |
| Point72 Asset Management | Q2 2026(8Q snapshot) | 1Q | $0.00 | — | — |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at ASTRAZENECA PLC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 22, 2026 — the most recent Form 4 on file — not from today.
Fundamentals
XBRL · ASTRAZENECA PLCNot enough XBRL history to plot. ASTRAZENECA PLChasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for ASTRAZENECA PLC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KADMISSION OF FURTHER SECURITIES TO TRADINGJun 1, 2026
- 6-KTOTAL VOTING RIGHTSJun 1, 2026
- 6-KIMFINZI APPROVED IN US FOR EARLY BLADDER CANCERMay 29, 2026
- 6-KUS FDA DECISION DATE ON CAMIZESTRANT EXTENDEDMay 27, 2026
- 6-KDATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BCMay 26, 2026
- 6-KENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURSMay 26, 2026
- 6-KCAMIZESTRANT RECOMMENDED FOR BREAST CANCER IN EUMay 26, 2026
- 6-KDIRECTOR/PDMR SHAREHOLDINGMay 18, 2026
- 6-KBAXFENDY APPROVED IN THE US FOR HYPERTENSIONMay 18, 2026
- 6-KENHERTU APPROVED IN TWO HER2+ EARLY BC SETTINGSMay 18, 2026
- 6-KIMFINZI + EV IMPROVES EFS & OS IN BLADDER CANCERMay 14, 2026
- 6-KTOTAL VOTING RIGHTS AND ADMISSION OF SHARESMay 1, 2026
- 6-KFDA ODAC VOTE ON CAMIZESTRANT IN BREAST CANCERMay 1, 2026
- 6-KFDA ODAC RECOMMENDS TRUQAP IN PROSTATE CANCERMay 1, 2026
- 6-K1ST QUARTER RESULTSApr 29, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $0.00 | — | +0% |
| Two Sigma Investments | Q2 2026 | open | $0.00 | — | +0% |
| D.E. Shaw | Q2 2026 | open | $0.00 | — | +0% |
| AQR Capital Management | Q2 2026 | open | $0.00 | — | +0% |
| Millennium Management | Q2 2026 | open | $0.00 | — | +0% |
| Point72 Asset Management | Q2 2026 | open | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.